EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Plasma eMTBR‐tau243 as a disease biomarker across Alzheimer's disease clinical phenotypes

Jennifer L Whitwell, Jerusha G Bhaskaran, Ryota Satoh, Jonathan Graff-Radford, Mary M Machulda, Val J Lowe, Michelle M Mielke, Dennis W Dickson, Shin-Cheng Tzeng, John Bui, Philip B Verghese, Tim West und 2 weitere

Alzheimer's & Dementia · 2026-10 · 22 (10)

DOI: 10.1002/alz.71898 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 09.10.2026. Verfasst von Jennifer L Whitwell und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, tau Proteins. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION The concentration of endogenous tau microtubule‐binding region containing residue‐243 in plasma (eMTBR‐tau243) has been proposed to be a sensitive biomarker of tangle pathology in Alzheimer's disease (AD). We assessed eMTBR‐tau243 and phosphorylated tau217 (p‐tau217) with tau and Aβ‐positron emission tomography (PET) across different AD clinical phenotypes. METHODS Plasma eMTBR‐tau243, p‐tau217, and the ratio of non‐phosphorylated to phosphorylated tau217 (%p‐tau217) were measured in 20 Aβ‐PET positive AD patients representing four clinical phenotypes and 10 cognitively unimpaired controls. Plasma levels were correlated with PET, demographic and cognitive variables. RESULTS Plasma eMTBR‐tau243, p‐tau217, and %p‐tau217 levels were greater in AD than controls, with greatest levels observed in motor‐predominant AD. Plasma biomarker levels correlated with cortical flortaucipir‐PET uptake; eMTBR‐tau243 correlations were strongest. In AD, eMTBR‐tau243 levels were undetectable in patients with mild/focal flortaucipir‐PET uptake (45%). Only eMTBR‐tau243 correlated with cognition. DISCUSSION Plasma eMTBR‐tau243 may be an excellent biomarker for tau deposition and cognition in AD across different phenotypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer Diseasetau ProteinsHumansFemaleBiomarkersPositron-Emission TomographyMaleAgedPhenotypeAmyloid beta-PeptidesPhosphorylationAged, 80 and overBrain

Stichwörter der Autor:innen

atypical Alzheimer's diseasecorticobasal syndromeflortaucipirlogopenicplasma biomarkerspositron emission tomographyposterior cortical atrophy

Substanzen

tau ProteinsBiomarkersAmyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Epidemiology and Prevention, Wake Forest University, Winston-Salem, North Carolina, USA.
  • Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
  • C2N Diagnostics, C2N Diagnostics LLC, St. Louis, Missouri, USA.

Förderung

  • NIA NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Whitwell, J. L., Bhaskaran, J. G., Satoh, R., Graff-Radford, J., Machulda, M. M., Lowe, V. J., Mielke, M. M., Dickson, D. W., Tzeng, S. C., Bui, J., Verghese, P. B., West, T., Venkatesh, V., & Josephs, K. A. (2026). Plasma eMTBR‐tau243 as a disease biomarker across Alzheimer's disease clinical phenotypes. Alzheimer's & Dementia, 22(10). https://doi.org/10.1002/alz.71898

Vancouver

Whitwell JL, Bhaskaran JG, Satoh R, Graff-Radford J, Machulda MM, Lowe VJ, et al. Plasma eMTBR‐tau243 as a disease biomarker across Alzheimer's disease clinical phenotypes. Alzheimer's & Dementia. 2026;22(10). doi:10.1002/alz.71898

BibTeX
@article{Whitwell2026,
  author = {Whitwell, Jennifer L and Bhaskaran, Jerusha G and Satoh, Ryota and Graff-Radford, Jonathan and Machulda, Mary M and Lowe, Val J and Mielke, Michelle M and Dickson, Dennis W and Tzeng, Shin-Cheng and Bui, John and Verghese, Philip B and West, Tim and Venkatesh, Venky and Josephs, Keith A},
  title = {Plasma eMTBR‐tau243 as a disease biomarker across Alzheimer's disease clinical phenotypes},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {10},
  doi = {10.1002/alz.71898}
}
Kostenlos starten →